CAR T Cells Activate Cancer Therapy

Abstract

CAR T cells modified to produce bacterial enzymes can activate tumor-killing prodrugs. The cells, dubbed SEAKER cells, home in on tumor cells, proliferate, and produce large quantities of the enzymes, which then activate the prodrug. The research demonstrates that CAR T cells' cancer-killing ability can be boosted in vitro and increase survival of mice with tumors.